Heron Therapeutics News

Heron Therapeutics Analyst Ratings

BenzingaApr 23 07:10 ET

Heron Therapeutics Analyst Ratings

BenzingaApr 11 06:00 ET

Needham Reiterates Buy on Heron Therapeutics, Maintains $5 Price Target

BenzingaApr 11 06:02 ET

Northland Securities Keeps Their Buy Rating on Heron Therapeutics (HRTX)

TipRanksMar 13 08:56 ET

Heron Therapeutics Analyst Ratings

BenzingaMar 13 06:26 ET

Heron Therapeutics (HRTX) Gets a Buy From Northland Securities

TipRanksJan 5 09:15 ET

Needham Maintains Buy on Heron Therapeutics, Lowers Price Target to $4

BenzingaNov 15, 2023 07:49 ET

Heron Therapeutics Analyst Ratings

BenzingaNov 15, 2023 07:47 ET

Analysts Offer Insights on Healthcare Companies: Asensus Surgical (ASXC), Cue Health (HLTH) and Heron Therapeutics (HRTX)

TipRanksNov 15, 2023 06:30 ET

Heron Therapeutics Analyst Ratings

BenzingaAug 15, 2023 06:33 ET

Needham Maintains Buy on Heron Therapeutics, Lowers Price Target to $5

BenzingaJul 25, 2023 04:13 ET

Heron Therapeutics Analyst Ratings

BenzingaJul 25, 2023 04:13 ET

Heron Therapeutics (HRTX) Gets a Buy From Needham

TipRanksApr 21, 2023 08:33 ET

Needham Reiterates Buy on Heron Therapeutics, Maintains $7 Price Target

BenzingaApr 21, 2023 06:55 ET

Evercore ISI Group Maintains Outperform on Heron Therapeutics, Lowers Price Target to $10

BenzingaMar 24, 2023 11:53 ET

Analysts Offer Insights on Healthcare Companies: Heron Therapeutics (HRTX), Monopar Therapeutics Inc (MNPR) and Werewolf Therapeutics (HOWL)

TipRanksMar 24, 2023 08:37 ET

Needham Adjusts Price Target on Heron Therapeutics to $7 From $8, Keeps Buy Rating

MT NewswiresMar 24, 2023 07:54 ET

Needham Remains a Buy on Heron Therapeutics (HRTX)

TipRanksJan 10, 2023 06:30 ET

Analysts Cut Price Targets As Heron Therapeutics' Zynrelef Disappoints In Q3

Benzinga Real-time NewsNov 9, 2022 13:16 ET

Needham Trims Price Target on Heron Therapeutics to $8 From $10, Maintains Buy Rating

MT NewswiresNov 9, 2022 10:09 ET